ALMR Financials

Income Statement
MetricQ2 2026
Revenue
29.4M
Cost of Revenue
11.7M
Gross Profit
17.7M
Operating Expenses
31.3M
R&D
13.8M
SG&A
17.4M
Operating Income
-13532000
EBITDA
-12398000
Net Income
-13199000
EPS (Basic)
$-0.22
EPS (Diluted)
$-0.22
Shares (Diluted)
58.7M
Alamar Biosciences (ALMR) โ€” Financials